BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8765816)

  • 21. Further studies of patients with both honeybee- and yellow-jacket-venom-specific IgE.
    Reisman RE; Wypych JI; Lazell MI
    Int Arch Allergy Appl Immunol; 1987; 82(2):190-4. PubMed ID: 3804461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuing venom immunotherapy.
    Golden DB
    Curr Opin Allergy Clin Immunol; 2001 Aug; 1(4):353-6. PubMed ID: 11964712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D; Bircher AJ; Scherer K
    J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for hymenoptera venom and biting insect hypersensitivity.
    Müller UR; Golden DB; Demarco PJ; Lockey RF
    Clin Allergy Immunol; 2004; 18():541-59. PubMed ID: 15042934
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hymenoptera sting challenge of 348 patients: relation to subsequent field stings.
    van Halteren HK; van der Linden PW; Burgers SA; Bartelink AK
    J Allergy Clin Immunol; 1996 May; 97(5):1058-63. PubMed ID: 8626982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW; Meusser-Storm S; Eger G
    Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
    Ruiz B; Serrano P; Moreno C
    J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mononuclear blood cell sulfidoleukotriene generation in the presence of interleukin-3 and whole blood histamine release in honey bee and yellow jacket venom allergy.
    Maly FE; Marti-Wyss S; Blumer S; Cuhat-Stark I; Wüthrich B
    J Investig Allergol Clin Immunol; 1997; 7(4):217-24. PubMed ID: 9330184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bee and wasp venom allergy in Turkey.
    Kalyoncu AF; Demir AU; Ozcan U; Ozkuyumcu C; Sahin AA; Bariş YI
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):408-12. PubMed ID: 9109709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
    Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wasp venom is appropriate for immunotherapy of patients with allergic reaction to the European hornet sting.
    Kosnik M; Korosec P; Silar M; Music E; Erzen R
    Croat Med J; 2002 Feb; 43(1):25-7. PubMed ID: 11828554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sting challenge: indications and execution].
    Ruëff F; Przybilla B
    Hautarzt; 2014 Sep; 65(9):796-801. PubMed ID: 25234628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and immunological studies of venom immunotherapy.
    Reisman RE; Arbesman CE; Lazell M
    Clin Allergy; 1979 Mar; 9(2):167-74. PubMed ID: 445786
    [No Abstract]   [Full Text] [Related]  

  • 37. Practice of venom immunotherapy in the United Kingdom: a national audit and review of literature.
    Diwakar L; Noorani S; Huissoon AP; Frew AJ; Krishna MT
    Clin Exp Allergy; 2008 Oct; 38(10):1651-8. PubMed ID: 18727621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
    van der Brempt X; Ledent C; Mairesse M
    Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bee-venom allergy in children: long-term predictive value of standardized challenge tests.
    Schuetze GE; Forster J; Hauk PJ; Friedl K; Kuehr J
    Pediatr Allergy Immunol; 2002 Feb; 13(1):18-23. PubMed ID: 12000494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.